Telmisartan (40mg) + Metoprolol (25mg)
The purpose of Telgard M 25 Tablet ER is to regulate hypertension (high blood pressure). It mitigates the chances of strokes and heart attacks by regulating blood pressure. It also enhances the survival rates of individuals who have experienced a heart attack.
Telgard M 25 Tablet ER is a combination medication that is prescribed to manage high blood pressure. Telmisartan and Metoprolol Succinate are combined to effectively lower blood pressure and reduce the risk of cardiovascular events. Following the instructions provided by your physician is crucial for minimizing potential adverse effects and achieving the best possible results.
Frequently, these effects diminish as your body acclimates to the medication. Contact your healthcare provider if any severe or persistent reactions occur.
1 Strip of 10 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Quantity: Adhere to the dosage and duration recommended by your physician.
Take: Take the tablet whole with water. Avoid crushing, chewing, or breaking it.
Food: To minimize stomach irritation and optimize absorption, consume Telgard M 25 Tablet ER with food.
Consistency: To ensure that the medication remains at consistent levels in your circulation, it is important to take it at the same specific time each day.
In the formulation of Telgard M 25 Tablet ER, there are two active ingredients:
Related Warnings
Refrain from consuming alcohol while taking Telgard M 25 Tablet ER, as it may elevate the likelihood of adverse effects, including drowsiness and vertigo.
Consult Your Physician: There are potential hazards to the developing fetus associated with the use of Telgard M 25 Tablet ER during pregnancy. Therefore, it is generally opposed. Seek the advice of your healthcare provider to address any potential risks and benefits.
Telgard M 25 Tablet ER is likely to be harmless during breastfeeding if prescribed. Nevertheless, verify with your physician that it does not present any substantial hazards to the infant.
The medication may result in vertigo or diminished alertness, rendering it unsafe for driving. Do not operate heavy apparatus or drive if you are experiencing these symptoms.
The Telgard M 25 Tablet ER is generally safe for use in patients with kidney disease, provided that it is prescribed. Dosage adjustments are not typically necessary; however, it is advisable to consult with your physician for personalized guidance.
For individuals with liver disease, Telgard M 25 Tablet ER should be used with caution. Additionally, dosage modifications may be required. To ascertain the appropriate dosage, consult your physician.
Q: Is it possible for Telgard M 25 Tablet ER to induce vertigo at all?
Indeed, vertigo may manifest, particularly when one abruptly gets up. In order to mitigate this risk, raise oneself gradually from a seated or supine position.
Q: While taking Telgard M 25 Tablet ER, what lifestyle modifications should I implement?
Enhance the efficacy of the medication by maintaining a healthy lifestyle that includes a balanced diet, consistent physical activity, nicotine cessation, and weight management.
Q: Is it possible to discontinue the use of Telgard M 25 Tablet ER if I experience an improvement in my health?
Do not discontinue the administration of Telgard M 25 Tablet ER as prescribed, regardless of your current state of health. Serious health complications may result from abruptly discontinuing the medication.
Q: What is the proper method for storing and disposing of Telgard M 25 Tablet ER?
Keep the medication in its original container, ensure that it is securely sealed, and adhere to the storage instructions specified on the label. Avoid placing any unused medication within the reach of children and pets. Properly dispose of it.
